Millennium Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.2M | Sell |
337,100
-267,100
| -44% | -$25.6M | 0.01% | 1255 |
|
|
2025
Q4 | $58M | Buy |
604,200
+317,400
| +111% | +$30.8M | 0.02% | 712 |
|
|
2025
Q3 | $27.3M | Sell |
286,800
-503,900
| -64% | -$46.3M | 0.01% | 1331 |
|
|
2025
Q2 | $68.9M | Sell |
790,700
-810,400
| -51% | -$68.7M | 0.03% | 622 |
|
|
2025
Q1 | $144M | Buy |
1,601,100
+1,444,100
| +920% | +$129M | 0.08% | 246 |
|
|
2024
Q4 | $12.5M | Sell |
157,000
-321,400
| -67% | -$27.8M | 0.01% | 1969 |
|
|
2024
Q3 | $43.1M | Buy |
478,400
+146,300
| +44% | +$12.3M | 0.02% | 931 |
|
|
2024
Q2 | $26.1M | Buy |
332,100
+107,000
| +48% | +$8.77M | 0.01% | 1268 |
|
|
2024
Q1 | $19.6M | Sell |
225,100
-151,800
| -40% | -$13M | 0.01% | 1575 |
|
|
2023
Q4 | $31M | Buy |
376,900
+7,500
| +2% | +$572K | 0.01% | 1176 |
|
|
2023
Q3 | $28.9M | Buy |
369,400
+124,700
| +51% | +$10.4M | 0.01% | 1121 |
|
|
2023
Q2 | $21.6M | Sell |
244,700
-142,000
| -37% | -$12.2M | 0.01% | 1320 |
|
|
2023
Q1 | $31.2M | Sell |
386,700
-226,600
| -37% | -$18.5M | 0.02% | 995 |
|
|
2022
Q4 | $47.7M | Sell |
613,300
-285,700
| -32% | -$23.2M | 0.03% | 779 |
|
|
2022
Q3 | $72.6M | Buy |
899,000
+117,600
| +15% | +$10.6M | 0.04% | 486 |
|
|
2022
Q2 | $70.1M | Buy |
781,400
+143,500
| +22% | +$14.5M | 0.04% | 458 |
|
|
2022
Q1 | $70.8M | Buy |
637,900
+59,500
| +10% | +$6.29M | 0.04% | 499 |
|
|
2021
Q4 | $59.8M | Buy |
578,400
+334,300
| +137% | +$38.7M | 0.03% | 623 |
|
|
2021
Q3 | $30.6M | Sell |
244,100
-10,100
| -4% | -$1.31M | 0.02% | 965 |
|
|
2021
Q2 | $31.6M | Sell |
254,200
-28,400
| -10% | -$3.57M | 0.02% | 865 |
|
|
2021
Q1 | $33.4M | Buy |
282,600
+65,800
| +30% | +$7.71M | 0.02% | 719 |
|
|
2020
Q4 | $25.4M | Buy |
216,800
+400
| +0.2% | +$44K | 0.02% | 887 |
|
|
2020
Q3 | $22.5K | Buy |
216,400
+125,200
| +137% | +$12.6M | 0.03% | 719 |
|
|
2020
Q2 | $8.36M | Sell |
91,200
-244,900
| -73% | -$23.5M | 0.01% | 1342 |
|
|
2020
Q1 | $30.3M | Sell |
336,100
-85,600
| -20% | -$9.11M | 0.07% | 298 |
|
|
2019
Q4 | $47.8M | Buy |
421,700
+154,800
| +58% | +$17M | 0.06% | 389 |
|
|
2019
Q3 | $29M | Buy |
266,900
+211,900
| +385% | +$22.1M | 0.05% | 579 |
|
|
2019
Q2 | $5.36M | Sell |
55,000
-10,400
| -16% | -$950K | 0.01% | 1710 |
|
|
2019
Q1 | $5.96M | Buy |
65,400
+25,400
| +64% | +$2.27M | 0.01% | 1633 |
|
|
2018
Q4 | $3.64M | Buy |
+40,000
| New | +$3.74M | 0.01% | 1802 |
|
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$2.57M | – | 4132 |
|
|
2018
Q2 | $2.57M | Hold |
30,000
| – | – | ﹤0.01% | 2232 |
|
|
2018
Q1 | $2.41M | Buy |
30,000
+20,000
| +200% | +$1.65M | ﹤0.01% | 2205 |
|
|
2017
Q4 | $808K | Sell |
10,000
-240,000
| -96% | -$19.2M | ﹤0.01% | 2824 |
|
|
2017
Q3 | $19.4M | Buy |
250,000
+100,000
| +67% | +$8.3M | 0.03% | 812 |
|
|
2017
Q2 | $13.3M | Buy |
150,000
+50,000
| +50% | +$4.22M | 0.02% | 894 |
|
|
2017
Q1 | $8.06M | Buy |
+100,000
| New | +$7.81M | 0.01% | 1151 |
|
|
2016
Q4 | – | Sell |
-35,000
| Closed | -$3.02M | – | 3558 |
|
|
2016
Q3 | $3.02M | Buy |
+35,000
| New | +$3.05M | 0.01% | 1654 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$7.5M | – | 3410 |
|
|
2016
Q1 | $7.5M | Buy |
+100,000
| New | +$7.53M | 0.02% | 1007 |
|
|
2013
Q4 | – | Sell |
-10,500
| Closed | -$559K | – | 3633 |
|
|
2013
Q3 | $559K | Buy |
+10,500
| New | +$565K | ﹤0.01% | 2468 |
|
Other funds holding MDT
VCM
VPM
Millennium Management's MDT Position: Q1 2026 in Review
Millennium Management reduced its Medtronic (MDT) stake by 84% in Q1 2026, selling an estimated $240M and leaving 472,273 shares worth $40.9M. The position accounts for 0.02% of the portfolio, ranked #982.
Millennium Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $560M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Millennium Management held 472,273 shares of Medtronic worth $40.9M as of Q1 2026.
- Millennium Management sold 2,503,215 Medtronic shares in Q1 2026, an estimated $240M.
- Medtronic made up 0.02% of Millennium Management's portfolio in Q1 2026, its #982 holding.
- Millennium Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Medtronic position peaked at $560M in Q3 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.